Evaluation of PAI-039 [{1-benzyl-5-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl}(oxo)acetic acid], a novel plasminogen activator inhibitor-1 inhibitor, in a canine model of coronary artery thrombosis. (Q55040836)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Evaluation of PAI-039 [{1-benzyl-5-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl}(oxo)acetic acid], a novel plasminogen activator inhibitor-1 inhibitor, in a canine model of coronary artery thrombosis. |
scientific article |
Statements
1 reference
Evaluation of PAI-039 [{1-benzyl-5-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl}(oxo)acetic acid], a novel plasminogen activator inhibitor-1 inhibitor, in a canine model of coronary artery thrombosis. (English)
1 reference
James K Hennan
1 reference
Hassan Elokdah
1 reference
Mauricio Leal
1 reference
Allena Ji
1 reference
Gregory S Friedrichs
1 reference
Gwen A Morgan
1 reference
Robert E Swillo
1 reference
Thomas M Antrilli
1 reference
Amy Hreha
1 reference
David L Crandall
1 reference
28 April 2005
1 reference
314
1 reference
2
1 reference
710-716
1 reference
Identifiers
1 reference